Palatin Technologies, Inc. to Report Fourth Quarter and Fiscal Year End 2018 Results; Teleconference and Webcast to be held on September 13, 2018

Sep 07, 2018, 16:00 ET

CRANBURY, N.J., Sept. 7, 2018 /PRNewswire/ — Palatin Technologies, Inc. (NYSE American: PTN) will announce its fourth quarter and fiscal year end 2018 operating results on Thursday, September 13, 2018  before the open of the U.S. financial markets.

Palatin will also conduct a conference call and live audio webcast hosted by its executive management team on September 13, 2018 at 11:00 a.m. ET. The conference call will include a review of the company’s operating results and an update on programs under development.

Schedule for the Operating Results Press Release, Conference Call / Audio Webcast



Q4 and Fiscal Year End 2018 Financial Results Press Release 

9/13/2018 at 7:30 a.m. ET



Q4 and Fiscal Year End 2018 Conference Call-Live                     

9/13/2018 at 11:00 a.m. ET

US/Canada Dial-In Number:                                                          

1-855-719-5012

International Dial-In Number:                                                        

1-334-323-0522

Conference ID:                                                                              

5577225



Q4 and Fiscal Year End 2018 Conference Call-Replay                

9/13/2018-9/20/2018

US/Canada Dial-In Number:                                                          

1-888-203-1112

International Dial-In Number:                                                        

1-719-457-0820

Replay Passcode:                                                                         

5577225



Audio Webcast Live and Replay Access                          

http://www.palatin.com

The audio webcast and replay can be accessed by logging on to the “Investors-Webcasts” section of Palatin’s website at http://www.palatin.com.

About Palatin Technologies, Inc.
Palatin Technologies, Inc. is a biopharmaceutical company developing targeted, receptor-specific peptide therapeutics for the treatment of diseases with significant unmet medical need and commercial potential. Palatin’s strategy is to develop products and then form marketing collaborations with industry leaders in order to maximize their commercial potential. For additional information, please visit http://www.palatin.com.

SOURCE Palatin Technologies, Inc.

Related Links

http://www.palatin.com

Scroll to Top